BAY1125976
CAS: 1402608-02-9
Ref. 3D-CGC60802
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen | ||
| 100mg | Nachfragen |
Produktinformation
BAY1125976 is a potent and selective CDK4/6 inhibitor. It binds to the ATP-binding site on these kinases, which are necessary for cell division. BAY1125976 has been shown to have an inhibitory effect on cancer cells in vitro and in vivo. It significantly reduces tumor growth without causing any adverse effects in the healthy cells. The primary mechanism of action is thought to be through inhibition of protein synthesis, which leads to reduced cell proliferation and decreased tumor growth. Bay 112596 is a potent and selective CDK4/6 inhibitor that binds to the ATP-binding site on these kinases, which are necessary for cell division. BAY 112596 has been shown to have an inhibitory effect on cancer cells in vitro and in vivo. It significantly reduces tumor growth without causing any adverse effects in the healthy cells. The primary mechanism of action is thought to be through inhibition of protein synthesis, which leads to reduced cell proliferation and decreased tumor growth
Chemische Eigenschaften
Technische Anfrage zu: 3D-CGC60802 BAY1125976
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
